NCT06192927View on ClinicalTrials.gov

Efficacy and Safety of TenoMiR in Lateral Epicondylitis

PHASE2CompletedINTERVENTIONAL
Enrollment

123

Participants

Timeline

Start Date

April 10, 2024

Primary Completion Date

March 3, 2025

Study Completion Date

June 12, 2025

Conditions
Tennis Elbow
Interventions
DRUG

TenoMiR

Single intralesional injection

DRUG

0.9% Sodium Chloride Injection

Single subcutaneous injection

Trial Locations (9)

10021

Hospital for Special Surgery, New York

10022

NYU Langone Health, New York

94063

Stanford Medicine, Redwood City

EN3 4GS

Panthera Biopartners, Enfield

G51 4TY

Panthera Biopartners, Glasgow

Unknown

Glasgow Clinical Research Facility, Glasgow

PR2 9QB

Panthera Biopartners, Preston

OL11 4AU

Panthera Biopartners, Rochdale

S2 5FX

Panthera Biopartners, Sheffield

Sponsors
All Listed Sponsors
lead

Causeway Therapeutics

INDUSTRY

NCT06192927 - Efficacy and Safety of TenoMiR in Lateral Epicondylitis | Biotech Hunter | Biotech Hunter